Advertisement
Screener

Nikola Corporation Spending and interest coverage

Nikola Corporation Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-12-31..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2024-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2024-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2024-12-31.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2024-12-31.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending158.06M USDResearch and Development Expense
Revenue(m)Revenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation31.97M USDShare-based Payment Arrangement, Noncash Expense
Operating income-916.46M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2024-12-31$158.06M(m)$31.97M$-916.46M(m)(m)(m)(m)(m)
2024-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$208.16M(m)$75.39M$-649.83M(m)(m)(m)(m)(m)
2023-09-30$234.42M(m)$110.15M$-671.37M(m)(m)(m)(m)(m)
2023-06-30$259.14M$55.74M$194.33M$-674.92M(m)464.88%348.62%(m)(m)
2023-03-31$257.73M$58.95M$223.40M$-678.53M(m)437.16%378.94%(m)(m)
2022-12-31$270.48M$49.73M$252.44M$-702.63M(m)543.95%507.68%(m)(m)
2022-09-30(m)$44.26M(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$292.95M$0.00$205.71M$-693.53M(m)(m)(m)(m)(m)
2021-09-30$269.31M$0.00(m)$-677.65M(m)(m)(m)(m)(m)
2021-06-30$241.91M$0.00(m)$-523.11M(m)(m)(m)(m)(m)
2021-03-31$216.71M$36.00K(m)$-471.33M(m)601958.33%(m)(m)(m)
2020-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30$140.88M$143.00K(m)$-263.83M(m)98516.78%(m)(m)(m)
2020-06-30$98.86M$439.00K(m)$-159.57M(m)22520.50%(m)(m)(m)
2020-03-31$68.19M$416.00K(m)$-90.16M(m)16392.79%(m)(m)(m)
2019-12-31$67.51M$482.00K(m)$-88.00M(m)14007.05%(m)(m)(m)
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.